Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report) traded down 7.5% on Wednesday . The stock traded as low as $15.53 and last traded at $15.58. 143,132 shares were traded during trading, a decline of 85% from the average session volume of 939,045 shares. The stock had previously closed at $16.85. Analysts Set […]
StoneCrest Wealth Management Inc Acquires New Shares in Viridian Therapeutics, Inc (NASDAQ:VRDN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Viridian Therapeutics (NASDAQ:VRDN – Free Report) had its price objective trimmed by B. Riley from $29.00 to $25.00 in a research note published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also issued reports on VRDN. HC Wainwright reiterated a buy rating and issued […]
Needham & Company LLC reaffirmed their buy rating on shares of Viridian Therapeutics (NASDAQ:VRDN – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a $30.00 price objective on the stock. Other analysts also recently issued reports about the stock. Oppenheimer lifted their price […]
Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) had its price objective decreased by research analysts at B. Riley from $29.00 to $25.00 in a research note issued on Thursday, Benzinga reports. The firm currently has a “buy” rating on the stock. B. Riley’s price objective suggests a potential upside of 38.81% from the stock’s current […]